Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

BioVie releases phase 2 trial results for Parkinson's Disease treatment

BioVie releases phase 2 trial results for Parkinson's Disease treatment

BioVie President & CEO Cuong Do joins Natalie Stoberman from the Proactive studio to share the company's latest updates from clinical trials on Parkinson's Disease.

BioVie is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. For more information visit https://bioviepharma.com/